MedTrace Logo

Osteopontin as a Biomarker in Pancreatitis

NCT05882500 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 103

Last updated 2023-05-31

No results posted yet for this study

Summary

In the early phase of pancreatits, factors that can give information about the development of severety are still lacking. In this study patients will be included prospectively upon the diagnosis of pancreatits and clinical as well as labarotory and radiological factors will be sampled. The aim is do identifiy factors that may aid in the risk stratification for development of different severity grades of pancreatitis.

Conditions

Interventions

OTHER

No intervention, observation

Sponsors & Collaborators

  • Linkoeping University

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-03
Primary Completion
2016-10-19
Completion
2023-01-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05882500 on ClinicalTrials.gov